| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |